Business Description
Novogene Co Ltd
ISIN : CNE1000052X3
Share Class Description:
SHSE:688315: Class ACompare
Compare
Traded in other countries / regions
688315.China IPO Date
2021-04-13Description
Novogene Co Ltd is engaged in providing multi-level scientific research and technical services and solutions for life science basic research, medical and clinical application research, and independent development and innovation of genetic testing medical equipment.
Financial Strength
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 33.94 | |||||
| Equity-to-Asset | 0.7 | |||||
| Debt-to-Equity | 0.02 | |||||
| Debt-to-EBITDA | 0.16 | |||||
| Interest Coverage | 156.58 | |||||
| Piotroski F-Score | 7/9 | |||||
| Altman Z-Score | 4.82 | |||||
| Beneish M-Score | -2.57 | |||||
| WACC vs ROIC | ||||||
Growth Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 6.7 | |||||
| 3-Year EBITDA Growth Rate | 28.9 | |||||
| 3-Year EPS without NRI Growth Rate | 37.7 | |||||
| 3-Year FCF Growth Rate | -7.7 | |||||
| 3-Year Book Growth Rate | 23.9 | |||||
| Future 3-5Y EPS without NRI Growth Rate | 25.83 | |||||
| Future 3-5Y Total Revenue Growth Rate | 15.48 |
Momentum Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 51.77 | |||||
| 9-Day RSI | 50.74 | |||||
| 14-Day RSI | 52.34 | |||||
| 6-1 Month Momentum % | 4.08 | |||||
| 12-1 Month Momentum % | -44.44 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 2.38 | |||||
| Quick Ratio | 2.2 | |||||
| Cash Ratio | 1.23 | |||||
| Days Inventory | 57.94 | |||||
| Days Sales Outstanding | 114.01 | |||||
| Days Payable | 37.92 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 0.36 | |||||
| Dividend Payout Ratio | 0.09 | |||||
| Forward Dividend Yield % | 0.36 | |||||
| 5-Year Yield-on-Cost % | 0.36 | |||||
| 3-Year Average Share Buyback Ratio | -5 | |||||
| Shareholder Yield % | 0.71 |
Profitability Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 42.48 | |||||
| Operating Margin % | 10.36 | |||||
| Net Margin % | 8.95 | |||||
| FCF Margin % | 8.42 | |||||
| ROE % | 7.95 | |||||
| ROA % | 5.53 | |||||
| ROIC % | 9.45 | |||||
| ROC (Joel Greenblatt) % | 25.99 | |||||
| ROCE % | 9.48 | |||||
| Years of Profitability over Past 10-Year | 9 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 28.85 | |||||
| Forward PE Ratio | 22.59 | |||||
| PE Ratio without NRI | 26.02 | |||||
| Price-to-Owner-Earnings | 72.93 | |||||
| PEG Ratio | 1.91 | |||||
| PS Ratio | 2.6 | |||||
| PB Ratio | 2.28 | |||||
| Price-to-Tangible-Book | 2.32 | |||||
| Price-to-Free-Cash-Flow | 31.38 | |||||
| Price-to-Operating-Cash-Flow | 16.29 | |||||
| EV-to-EBIT | 18.95 | |||||
| EV-to-EBITDA | 18.95 | |||||
| EV-to-Revenue | 2.07 | |||||
| EV-to-FCF | 23.97 | |||||
| Price-to-Projected-FCF | 1.75 | |||||
| Price-to-Graham-Number | 1.64 | |||||
| Price-to-Net-Current-Asset-Value | 4.11 | |||||
| Price-to-Net-Cash | 28.85 | |||||
| Earnings Yield (Greenblatt) % | 5.28 | |||||
| FCF Yield % | 3.19 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Novogene Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ¥) | 2,092.21 | ||
| EPS (TTM) (Â¥) | 0.46 | ||
| Beta | 1.66 | ||
| Volatility % | 50.34 | ||
| 14-Day RSI | 52.34 | ||
| 14-Day ATR (Â¥) | 0.629814 | ||
| 20-Day SMA (Â¥) | 13.414 | ||
| 12-1 Month Momentum % | -44.44 | ||
| 52-Week Range (Â¥) | 9.03 - 24.96 | ||
| Shares Outstanding (Mil) | 416.2 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 7 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Novogene Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Novogene Co Ltd Stock Events
| Event | Date | Price(Â¥) | ||
|---|---|---|---|---|
| No Event Data | ||||
Novogene Co Ltd Frequently Asked Questions
What is Novogene Co Ltd(SHSE:688315)'s stock price today?
The current price of SHSE:688315 is ¥13.27. The 52 week high of SHSE:688315 is ¥24.96 and 52 week low is ¥9.03.
When is next earnings date of Novogene Co Ltd(SHSE:688315)?
The next earnings date of Novogene Co Ltd(SHSE:688315) is .
Does Novogene Co Ltd(SHSE:688315) pay dividends? If so, how much?
The Dividend Yield %  of Novogene Co Ltd(SHSE:688315) is 0.36% (As of Today), Highest Dividend Payout Ratio of Novogene Co Ltd(SHSE:688315) was 0.16. The lowest was 0.09. And the median was 0.15. The  Forward Dividend Yield % of Novogene Co Ltd(SHSE:688315) is 0.36%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers